Leerink Partners
North America, Massachusetts, United States, Boston
Description
Describes equity research, investment banking, and asset management services.
Investor Profile
Leerink Partners has backed more than 17 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 6% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (53%)
- Series C (35%)
- Series Unknown (6%)
- Series A (6%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Genetics
- Biopharma
- Oncology
- Pharmaceutical
- Life Science
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
